000 01318 a2200373 4500
005 20250517230605.0
264 0 _c20190211
008 201902s 0 0 chi d
022 _a0253-3758
024 7 _a10.3760/cma.j.issn.0253-3758.2018.07.008
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZhang, X J
245 0 0 _a[Comparison of safety between continued warfarin therapy and bridging anticoagulation therapy in patients undergoing coronary intervention].
_h[electronic resource]
260 _bZhonghua xin xue guan bing za zhi
_cJul 2018
300 _a549-553 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnticoagulants
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aMyocardial Infarction
650 0 4 _aPercutaneous Coronary Intervention
650 0 4 _aRetrospective Studies
650 0 4 _aTreatment Outcome
650 0 4 _aWarfarin
_xadministration & dosage
700 1 _aYan, H B
700 1 _aChi, Y P
700 1 _aZhao, Q M
700 1 _aTian, L
700 1 _aZhang, M
700 1 _aWang, G Z
700 1 _aZhang, X X
700 1 _aChen, Q
773 0 _tZhonghua xin xue guan bing za zhi
_gvol. 46
_gno. 7
_gp. 549-553
856 4 0 _uhttps://doi.org/10.3760/cma.j.issn.0253-3758.2018.07.008
_zAvailable from publisher's website
999 _c28656301
_d28656301